Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults

References

• Jewkes J, Kay PH, Paneth M, Citron KM. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 1983; 38: 572–578.
   PubMed Web of Science ®Google Scholar
• Smith N, Denning DW. Underlying pulmonary disease frequency in patients with chronic pulmonary aspergillosis. Eur Respir J 2011; 37: 865–872.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillushypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009; 13: 936–944.
   PubMed Web of Science ®Google Scholar
• Patterson K, Strek ME. Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc 2010; 7: 237–244.
   PubMedGoogle Scholar
• Denning DW. Chronic aspergillosis. In: Aspergillus fumigatus and Aspergillosis. Latge JP, Steinbach WJ(eds). Washington DC, USA: ASM Press, 2009.
   Google Scholar
• Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37: S265–280.
   PubMed Web of Science ®Google Scholar
• Camuset J, Nunes H, Dombret MC, et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 2007; 31: 1435–1441.
   Google Scholar
• Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756–762.
   PubMed Web of Science ®Google Scholar
• Wark PA, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111: 952–957.
   PubMed Web of Science ®Google Scholar
• Nam HS, Jeon K, Um SW, et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 2010; 14: e479–482.
   PubMed Web of Science ®Google Scholar
• Felton TW, Baxter C, Roberts S, Hope WW, Denning DW. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 2010; 51: 1383–1391.
   PubMed Web of Science ®Google Scholar
• Kohno S, Izumikawa K, Ogawa K, et al. Japan Chronic Pulmonary Aspergillosis Study Group (JCPASG). Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan. J Infect 2010; 61: 410–418.
   PubMed Web of Science ®Google Scholar
• Beasley R. The Global Burden of Asthma Report; Global Initiative for Asthma (GINA) www.ginasthma.org/ReportItem.asp. Date last updated. 2004. Accessed March 3, 2010.
   Google Scholar
• Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, World Population Prospects: The 2008 Revision, http://esa.un.org/unpp, Accessed January 26, 2010.
   Google Scholar
• NHS Confederation, British Medical Association. New GMS Contract 2003:Investing in General Practice. London. March 2003.
   Google Scholar
• Anandan C, Gupta R, Simpson CR, Fischbacher C, Sheikh A. Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases. J R Soc Med 2009; 102: 431–442.
   PubMed Web of Science ®Google Scholar
• Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States, 2005–2009. Natl Health Stat Report. 2011; Jan 12; 32: 1–14.
   PubMedGoogle Scholar
• Benatar SR, Keen GA, Du Toit Naude W. Aspergillushypersensitivity in asthmatics in Cape Town. Clin Allergy 1980; 10: 285–291.
   Google Scholar
• Donnelly SC, McLaughlin H, Bredin CP. Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985–88. Ir J Med Sci 1991; 160: 288–290.
   PubMed Web of Science ®Google Scholar
• Eaton T, Garrett J, Milne D, Frankel A, Wells AU. Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest 2000; 118: 66–72.
   PubMedGoogle Scholar
• Al-Mobeireek AF, El-Rab MOG, Al-Hedaithy SS, et al. Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia. Respir Med 2001; 95: 341–347.
   Google Scholar
• Ma YL, Zhang WB, Yu B, et al. Prevalence of allergic bronchopulmonary aspergillosis in Chinese patients with bronchial asthma. Zhonghua Jie He He Hu Xi Za Zhi 2011; 34: 909–913.
   Google Scholar
• Khan ZU, Sandhu RS, Randhawa HS, Menon MP, Dusaj IS. Allergic bronchopulmonary aspergillosis: a study of 46 cases with special reference to laboratory aspects. Scand J Respir Dis 1976; 57: 73–87.
   PubMedGoogle Scholar
• Maurya V, Gugnani HC, Sarma PU, Madan T, Shah A. Sensitization to Aspergillusantigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest 2005; 127: 1252–1259.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Gupta D, Aggarwal AN, et al. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 2007; 132: 1183–1190.
   PubMed Web of Science ®Google Scholar
• Ghosh T, Dey A, Biswas D, et al. Aspergillushypersensitivity and allergic bronchopulmonary aspergillosis among asthma patients in eastern India. J Indian Med Assoc 2010; 108: 863–865.
   Google Scholar
• Ricketti AJ, Greenberger PA, Mintzer RA, Patterson R. Allergic bronchopulmonary aspergillosis. Arch Intern Med 1983; 143: 1553–1557.
   PubMedGoogle Scholar
• Patterson R, Greenberger PA, Harris KE. Allergic bronchopulmonary aspergillosis. Chest 2000; 118: 7–8.
   PubMed Web of Science ®Google Scholar
• Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Social Res Methodol 2005; 8: 19–32.
   Google Scholar
• McCarthy DS, Simon G, Hargreave FE. The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol 1970; 21: 366–375.
   PubMedGoogle Scholar
• Menon MP, Das AK. Allergic bronchopulmonary aspergillosis (radiological aspects). Indian J Chest Dis Allied Sci 1977; 19: 157–169.
   Google Scholar
• Gefter WB, Epstein DM, Miller WT. Allergic bronchopulmonary aspergillosis; less common patterns. Radiology 1981; 140: 307–312.
   Google Scholar
• Phelan MS, Kerr IH. Allergic broncho-pulmonary aspergillosis: the radiological appearance during long-term follow-up. Clin Radiol 1984; 35: 385–392.
   Google Scholar
• Panchal N, Bhagat R, Pant C, Shah A. Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir Med 1997; 91: 213–219.
   PubMedGoogle Scholar
• Nafti S, Taright S, El Ftouh M, et al. Prevalence of asthma in North Africa: the Asthma Insights and Reality in the Maghreb (AIRMAG) study. Respir Med 2009; 103(Suppl. 2): S2–11.
   Google Scholar
• Bousquet J, Kiley J, Bateman ED, et al. Prioritized research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010; 36: 995–1001.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). The global burden of disease: 2004 update. Geneva (2008). Accessed at http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html
   Google Scholar
• Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010; 376: 803–813.
   PubMed Web of Science ®Google Scholar
• Siroux V, Pin I, Pison C, Kauffmann F. Severe asthma in the general population: definition and prevalence. Rev Mal Respir 2004; 21: 961–969.
   Google Scholar
• Zureik M, Neukirch C, Leynaert B, et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. Br Med J 2002; 325: 411–415.
   PubMed Web of Science ®Google Scholar
• CDC FASTSTATS. www.cdc.gov/asthma_fast_facts_statistics.pdf. Accessed August 19, 2010.
   Google Scholar
• Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135: 805–826.
   PubMed Web of Science ®Google Scholar
• Knutsen AP, Bush R, Demain JD, et al. Fungi and allergic respiratory diseases. J Allergy Clin Immunol 2012; 129: 280–291.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillushypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses 2010; 53: 138–143.
   PubMed Web of Science ®Google Scholar
• Gergen PJ, Arbes SJ Jr, Calatroni A, Mitchell HE, Zeldin DC. Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol 2009; 124: 447–453.
   PubMed Web of Science ®Google Scholar
• Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and asthma – a summary of the evidence. Eur Resp J 2006; 27: 615–626.
   PubMed Web of Science ®Google Scholar
• Denning DW, O’Driscoll BR, Powell G, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitisation (SAFS), the FAST study. Am J Resp Crit Care Med 2009; 179: 11–18.
   PubMedGoogle Scholar
• Anonymous. Aspergilloma and residual tuberculous cavities – the results of a resurvey. Tubercle 1970; 51: 227–245.
   Google Scholar
• Hammerman KJ, Christianson CS, Huntington I, et al. Spontaneous lysis of aspergillomata. Chest 1973; 64: 677–679.
   Google Scholar
• Denning DW, Park S, Lass-Florl C, et al. High frequency triazole resistance found in non-culturable Aspergillus fumigatusfrom lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52: 1123–1129.
   PubMed Web of Science ®Google Scholar